Cargando…

Can Adjuvant HPV Vaccination Be Helpful in the Prevention of Persistent/Recurrent Cervical Dysplasia after Surgical Treatment?—A Literature Review

SIMPLE SUMMARY: Primary prophylactic, early detection and the treatment of precancerous lesions are the main goals of cervical cancer screening. Despite effective surgical treatment methods, using loop electrosurgical excision procedures and conization, the overall risk of the recurrence of HSIL les...

Descripción completa

Detalles Bibliográficos
Autores principales:	Michalczyk, Kaja, Misiek, Marcin, Chudecka-Głaz, Anita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496656/ https://www.ncbi.nlm.nih.gov/pubmed/36139514 http://dx.doi.org/10.3390/cancers14184352

Ejemplares similares

Can the Determination of HE4 and CA125 Markers Affect the Treatment of Patients with Endometrial Cancer?
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2021)

Evaluation of He4 Use in the Diagnosis of Ovarian Cancer: First and Second Recurrence, and an Analysis of HE4 Concentration during Second- and Third-Line Chemotherapy
por: Chudecka-Głaz, Anita, et al.
Publicado: (2023)

Adjuvant HPV Vaccination to Prevent Recurrent Cervical Dysplasia after Surgical Treatment: A Meta-Analysis
por: Di Donato, Violante, et al.
Publicado: (2021)

The Diagnostic Role of FGF 21 in Endometrial Cancer and Other Pathologies of the Uterine Corpus
por: Jagodzińska, Anna, et al.
Publicado: (2023)

Age Matters: The Moderating Effect of Age on Styles and Strategies of Coping with Stress and Self-Esteem in Patients with Neoplastic Prostate Hyperplasia
por: Skwirczyńska, Edyta, et al.
Publicado: (2023)

Outcomes of High-Grade Cervical Dysplasia with Positive Margins and HPV Persistence after Cervical Conization
por: Giannini, Andrea, et al.
Publicado: (2023)

HPV immunohistochemical testing and cervical dysplasia
por: MUREŞAN, DANIEL, et al.
Publicado: (2016)

Can ROMA algorithm stratify ovarian tumor patients better when being based on specific age ranges instead of the premenopausal and postmenopausal status?
por: Chudecka-Głaz, Anita, et al.
Publicado: (2016)

Evaluation of serum levels of sCD30L ligand in patients with ovarian cancer in terms of selected clinico-pathological factors
por: Chudecka-Głaz, Anita, et al.
Publicado: (2013)

Development of a Nomogram Predicting the Risk of Persistence/Recurrence of Cervical Dysplasia
por: Bogani, Giorgio, et al.
Publicado: (2022)

Surgical Treatment of Vulvar HSIL: Adjuvant HPV Vaccine Reduces Recurrent Disease
por: Ghelardi, Alessandro, et al.
Publicado: (2021)

Positive Surgical Margin, HPV Persistence, and Expression of Both TPX2 and PD-L1 Are Associated with Persistence/Recurrence of Cervical Intraepithelial Neoplasia after Cervical Conization
por: Zhang, Hui, et al.
Publicado: (2015)

Importance of Potential New Biomarkers in Patient with Serouse Ovarian Cancer
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2021)

Cervical and anal HPV infection and dysplasia in HIV-infected women
por: Stier, EA, et al.
Publicado: (2009)

Persistent HPV-16 infection leads to recurrence of high-grade cervical intraepithelial neoplasia
por: Byun, Jung Mi, et al.
Publicado: (2018)

HE4 Serum Levels in Patients with BRCA1 Gene Mutation Undergoing Prophylactic Surgery as well as in Other Benign and Malignant Gynecological Diseases
por: Chudecka-Głaz, Anita, et al.
Publicado: (2017)

Could HE4 level measurements during first-line chemotherapy predict response to treatment among ovarian cancer patients?
por: Chudecka-Głaz, Anita, et al.
Publicado: (2018)

Ectopic pregnancy treatment by combination therapy
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2016)

HPV genotyping and p16/Ki-67 test significantly improve detection rate of high-grade cervical squamous intraepithelial lesion
por: Lewitowicz, Piotr, et al.
Publicado: (2019)

Diagnostic usefulness of the Risk of Ovarian Malignancy Algorithm using the electrochemiluminescence immunoassay for HE4 and the chemiluminescence microparticle immunoassay for CA125
por: Chudecka-Głaz, Anita, et al.
Publicado: (2016)

Implications of Persistent HPV52 and HPV58 Positivity for the Management of Cervical Lesions
por: Yi, Baozhu, et al.
Publicado: (2022)

Cervical dysplasia in elderly women performing repeated self-sampling for HPV testing
por: Lindström, Annika Kristina, et al.
Publicado: (2018)

Can prophylactic HPV vaccination reduce the recurrence of cervical lesions after surgery? Review and prospect
por: Han, Ling, et al.
Publicado: (2023)

Pregnancy as a Risk Factor of Severe COVID-19
por: Celewicz, Aleksander, et al.
Publicado: (2021)

SARS CoV-2 infection as a risk factor of preeclampsia and pre-term birth. An interplay between viral infection, pregnancy-specific immune shift and endothelial dysfunction may lead to negative pregnancy outcomes
por: Celewicz, Aleksander, et al.
Publicado: (2023)

Endometrial Cancer Management in Young Women
por: Markowska, Anna, et al.
Publicado: (2022)

The Significance of Adaptation and Coping with Disease among Patients with Diagnosed Gynaecological Cancer in the Context of Disease Acceptance
por: Wieder-Huszla, Sylwia, et al.
Publicado: (2022)

HPV prevalence and HPV-related dysplasia in elderly women
por: Hermansson, Ruth S., et al.
Publicado: (2018)

Clinical Relevance of NGAL/MMP-9 Pathway in Patients with Endometrial Cancer
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2017)

Double-Emulsion Copolyester Microcapsules for Sustained Intraperitoneal Release of Carboplatin
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2019)

Prevalence of HPV types in HIV‐positive and negative females with normal cervical cytology or dysplasia
por: Aziz, Hafsa, et al.
Publicado: (2023)

From potential to practice: how accelerating access to HPV tests and screen and treat programmes can help eliminate cervical cancer
por: Cherniak, William, et al.
Publicado: (2019)

Incidence of HPV and HPV related dysplasia in elderly women in Sweden
por: Lannér, Lars, et al.
Publicado: (2020)

HPV16 persistent infection and recurrent disease after LEEP
por: Bruno, Maria Teresa, et al.
Publicado: (2019)

Risk Model in Women with Ovarian Cancer Without Mutations
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2018)

The Suitability of FGF21 and FGF23 as New Biomarkers in Endometrial Cancer Patients
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2020)

Efficacy of HPV Vaccination in Women Receiving LEEP for Cervical Dysplasia: A Single Institution’s Experience
por: Petrillo, Marco, et al.
Publicado: (2020)

Evidence of latent HPV infection in older Danish women with a previous history of cervical dysplasia
por: Hammer, Anne, et al.
Publicado: (2022)

Common Genetic Variants and Risk for HPV Persistence and Progression to Cervical Cancer
por: Wang, Sophia S., et al.
Publicado: (2010)

HE4 tumor marker concentration in neoplastic peritoneal effusion and in peritoneal fluid associated with benign gynecological diseases
por: Chudecka-Głaz, Anita, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_se59t2henth850qo19nrj1i2vj